Company page
Gossamer Bio, Inc.
Gossamer Bio, Inc. is a public company traded under the ticker GOSS in the American market. The company has a market capitalization of approximately $66.5 million. Gossamer Bio focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- GOSS:NASDAQ
- Asset type
- Stock
- Market cap
- $75.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD